PortfoliosLab logo

Arrowhead Pharmaceuticals, Inc. (ARWR)

Equity · Currency in USD · Last updated Sep 9, 2022

Company Info

ISINUS04280A1007
CUSIP04280A100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$39.42
Year Range$27.79 - $82.51
EMA (50)$41.52
EMA (200)$47.96
Average Volume$758.99K
Market Capitalization$4.17B

ARWRShare Price Chart


Chart placeholderClick Calculate to get results

ARWRPerformance

The chart shows the growth of $10,000 invested in Arrowhead Pharmaceuticals, Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $72,537 for a total return of roughly 625.37%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%AprilMayJuneJulyAugustSeptember
-6.25%
-4.71%
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARWRReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-16.70%-3.23%
6M-12.14%-6.35%
YTD-40.92%-15.95%
1Y-40.31%-11.37%
5Y66.11%10.25%
10Y31.22%10.81%

ARWRMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-20.42%-16.60%4.52%-10.61%-18.85%5.55%20.79%-6.63%-1.36%
20210.57%3.23%-16.76%9.73%-0.22%14.08%-16.34%-3.13%-6.99%2.23%9.76%-5.35%
2020-33.93%-15.63%-18.64%19.67%-6.36%33.96%-0.28%-1.93%1.94%33.07%9.13%22.71%
201913.69%38.24%-5.99%-2.02%31.87%11.77%9.66%17.58%-17.53%42.12%82.30%-13.12%
201867.93%4.85%11.27%-10.96%66.98%26.87%7.13%1.30%29.88%-33.65%14.15%-14.46%
201725.16%16.49%-18.14%-16.22%-7.10%12.50%8.64%59.09%54.64%-15.94%-1.92%3.08%
2016-43.41%12.07%23.59%20.12%5.87%-13.21%12.03%16.28%6.06%-21.09%-75.17%7.64%
2015-14.50%19.33%-10.16%2.00%-8.70%13.49%-13.57%-4.05%-2.87%-10.59%22.72%-2.69%
201441.38%26.73%-15.53%-33.50%15.21%13.75%-11.60%15.18%1.37%-55.86%-10.74%26.80%
2013-9.35%11.29%0.97%-5.50%6.80%-9.09%88.50%10.08%37.11%23.02%17.57%31.83%
201212.89%13.95%18.37%-9.25%-30.92%-4.00%-3.65%-27.57%-2.24%-3.82%-12.30%-3.17%
2011-2.79%-21.84%10.29%-19.80%-10.22%-5.63%4.00%3.77%-29.18%29.27%22.54%-32.09%
20105.56%-7.02%115.09%34.21%-11.76%-18.52%6.36%-22.22%15.38%-5.87%-3.89%-5.79%

ARWRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arrowhead Pharmaceuticals, Inc. Sharpe ratio is -0.63. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.63
-0.53
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARWRDividend History


Arrowhead Pharmaceuticals, Inc. doesn't pay dividends

ARWRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-56.70%
-16.48%
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARWRWorst Drawdowns

The table below shows the maximum drawdowns of the Arrowhead Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arrowhead Pharmaceuticals, Inc. is 95.33%, recorded on Dec 16, 2016. It took 619 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.33%Mar 11, 2014701Dec 16, 2016619Jun 6, 20191320
-90.86%Jun 7, 2010726Apr 24, 2013202Feb 11, 2014928
-71.84%Dec 2, 201974Mar 18, 2020186Dec 10, 2020260
-69.28%Feb 8, 2021343Jun 16, 2022
-27.19%Mar 24, 20103Mar 26, 20102Mar 30, 20105
-25%Jan 26, 201024Mar 1, 201015Mar 22, 201039
-22.66%Aug 30, 201920Sep 27, 201914Oct 17, 201934
-19.35%Apr 30, 20105May 6, 201019Jun 3, 201024
-14.92%Dec 24, 20207Jan 5, 202122Feb 5, 202129
-13.41%Feb 24, 20145Feb 28, 20143Mar 5, 20148

ARWRVolatility Chart

Current Arrowhead Pharmaceuticals, Inc. volatility is 68.99%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%AprilMayJuneJulyAugustSeptember
68.99%
22.96%
ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (^GSPC)